| pubmed-article:10702795 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C1707257 | lld:lifeskim |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C0008633 | lld:lifeskim |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C0035687 | lld:lifeskim |
| pubmed-article:10702795 | lifeskim:mentions | umls-concept:C1521285 | lld:lifeskim |
| pubmed-article:10702795 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:10702795 | pubmed:dateCreated | 2000-3-16 | lld:pubmed |
| pubmed-article:10702795 | pubmed:abstractText | The hyaluronidase first isolated from human plasma, Hyal-1, is expressed in many somatic tissues. The Hyal-1 gene, HYAL1, also known as LUCA-1, maps to chromosome 3p21.3 within a candidate tumor suppressor gene locus defined by homozygous deletions and by functional tumor suppressor activity. Hemizygosity in this region occurs in many malignancies, including squamous cell carcinomas of the head and neck. We have investigated whether cell lines derived from such malignancies expressed Hyal-1 activity, using normal human keratinocytes as controls. Hyal-1 enzyme activity and protein were absent or markedly reduced in six of seven carcinoma cell lines examined. Comparative genomic and fluorescence in situ hybridization identified chromosomal deletions of one allele of HYAL1 in six of seven cell lines. Initial RT - PCR analyses demonstrated marked discrepancies between levels of HYAL1 mRNA and protein. Despite repeated sequence analyses, no mutations were found. However, two species of transcripts were identified when primers were used that included the 5' untranslated region. The predominant mRNA species did not correlate with protein translation and contained a retained intron. A second spliced form lacking this intron was found only in cell lines that produced Hyal-1 protein. Inactivation of HYAL1 in these tumor lines is a result of incomplete splicing of its pre-mRNA that appears to be epigenetic in nature. Oncogene (2000) 19, 870 - 877. | lld:pubmed |
| pubmed-article:10702795 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10702795 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10702795 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10702795 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10702795 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10702795 | pubmed:issn | 0950-9232 | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:WongT MTM | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:SternRR | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:GrayJ WJW | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:MohapatraGG | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:FrostG IGI | lld:pubmed |
| pubmed-article:10702795 | pubmed:author | pubmed-author:CsókaA BAB | lld:pubmed |
| pubmed-article:10702795 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10702795 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:10702795 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:10702795 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10702795 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10702795 | pubmed:pagination | 870-7 | lld:pubmed |
| pubmed-article:10702795 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:meshHeading | pubmed-meshheading:10702795... | lld:pubmed |
| pubmed-article:10702795 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10702795 | pubmed:articleTitle | HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. | lld:pubmed |
| pubmed-article:10702795 | pubmed:affiliation | Department of Pathology, School of Medicine, University of California, San Francisco, California, CA 94143, USA. | lld:pubmed |
| pubmed-article:10702795 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10702795 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10702795 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| entrez-gene:3373 | entrezgene:pubmed | pubmed-article:10702795 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10702795 | lld:pubmed |
